litlas
Log inCreate account

Niklas Loman

Active 1997–2024

57
Papers
18,753
Citations
47
h-index
57
i10-index

Citations

Citations per year for Niklas Loman1996: 2 citations1997: 2 citations1998: 9 citations1999: 19 citations2000: 14 citations2001: 48 citations2002: 93 citations2003: 96 citations2004: 121 citations2005: 138 citations2006: 106 citations2007: 116 citations2008: 94 citations2009: 87 citations2010: 136 citations2011: 216 citations2012: 203 citations2013: 197 citations2014: 206 citations2015: 203 citations2016: 248 citations2017: 238 citations2018: 216 citations2019: 587 citations2020: 671 citations2021: 605 citations2022: 434 citations2023: 301 citations2024: 493 citations2025: 231 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,290 citing papers, 24.3% of this breakdownUnited Kingdom: 735 citing papers, 7.8% of this breakdownChina: 711 citing papers, 7.6% of this breakdownItaly: 447 citing papers, 4.7% of this breakdownCanada: 422 citing papers, 4.5% of this breakdownGermany: 383 citing papers, 4.1% of this breakdownFrance: 347 citing papers, 3.7% of this breakdownAustralia: 319 citing papers, 3.4% of this breakdownSweden: 305 citing papers, 3.2% of this breakdownSpain: 297 citing papers, 3.2% of this breakdownNetherlands: 248 citing papers, 2.6% of this breakdownJapan: 190 citing papers, 2% of this breakdown
0%24.3%Other 28.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology52.2%
  • Medicine40.8%
  • Immunology and Microbiology2.3%
  • Computer Science1.8%
  • Mathematics0.8%
  • Engineering0.3%
  • Other1.8%

Topics

  • BRCA gene mutations in cancer9.2%
  • PARP inhibition in cancer therapy8%
  • DNA Repair Mechanisms5.1%
  • Cancer Genomics and Diagnostics4.2%
  • Breast Cancer Treatment Studies4.2%
  • Ovarian cancer diagnosis and treatment3.5%
  • Other65.8%

Coauthors

All papers

Open in search
  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Authors: Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross, Priya Rastogi, Karen Cui, Amal Arahmani, Gursel Aktan, Anne Armstrong, Mónica Arnedos, Judith Balmaña, Jonas Bergh, Judith M. Bliss, Suzette Delaloge, Susan M. Domchek, Andrea Eisen, F. Elsafy, L.E. Fein, Anitra Fielding, James M. Ford, Sue Friedman, Karen A. Gelmon, Luca Gianni, Michael Gnant, Simon J. Hollingsworth, Seock‐Ah Im, Agnes Jager, Oskar T. Johannsson, Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke and 509 more - Annals of Oncology 2022 cited by 447

  2. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

    Authors: Asís Palazón, Petros A. Tyrakis, David Macías, Pedro Veliça, Helene Rundqvist, Susan F. Fitzpatrick, Nikola Vojnović, Anthony T. Phan, Niklas Loman, Ingrid Hedenfalk, Thomas Hatschek, John Lövrot, Theodoros Foukakis, Ananda W. Goldrath, Jonas Bergh, Randall S. Johnson - Cancer Cell 2017 cited by 530

  3. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

    Authors: Antonis C. Antoniou, Paul D.P. Pharoah, Steven A. Narod, Harvey A. Risch, J.E. Eyfjörd, John L. Hopper, Niklas Loman, Håkan Olsson, Oskar T. Johannsson, Åke Borg, Barbara Pasini, Paolo Radice, Siranoush Manoukian, Diana Eccles, Nelson L.S. Tang, Edith Oláh, Hoda Anton‐Culver, Ellen Warner, Jan Lubiński, Jacek Gronwald, Bohdan Górski, Hrafn Tulinius, Steinunn Thorlacius, Hannaleena Eerola, Heli Nevanlinna, Kirsi Syrjäkoski, Olli Kallioniemi, Deborah J. Thompson, Chris Evans, Julian Peto, Fiona Lalloo, D. Gareth Evans, Douglas F. Easton - The American Journal of Human Genetics 2003 cited by 3,685

  4. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

    Authors: Bella Kaufman, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek - Journal of Clinical Oncology 2014 cited by 1,678

  5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

    Authors: M. William Audeh, James Carmichael, Richard T. Penson, Michael Friedländer, Bethan Powell, Katherine M. Bell‐McGuinn, Clare L. Scott, Jeffrey N. Weitzel, Ana Oaknin, Niklas Loman, Karen H. Lu, Rita K. Schmutzler, Ursula A. Matulonis, Mark Wickens, Andrew Tutt - The Lancet 2010 cited by 2,283

  6. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    Authors: Johan Staaf, Dominik Głodzik, Ana Bosch, Johan Vallon‐Christersson, Christel Reuterswärd, Jari Häkkinen, Andrea Degasperi, Tauanne Dias Amarante, Lao H. Saal, Cecilia Hegardt, Hilary Stobart, Anna Ehinger, Christer Larsson, Lisa Rydén, Niklas Loman, Martin Malmberg, Anders Kvist, Hans Ehrencrona, Helen Davies, Åke Borg, Serena Nik‐Zainal - Nature Medicine 2019 cited by 317

  7. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    Authors: Andrew Tutt, Mark E. Robson, Judy E. Garber, Susan M. Domchek, M. William Audeh, Jeffrey N. Weitzel, Michael Friedländer, Banu Arun, Niklas Loman, Rita K. Schmutzler, Andrew Wardley, Gillian Mitchell, Helena Earl, Mark Wickens, James Carmichael - The Lancet 2010 cited by 1,636

  8. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

    Authors: Lao H. Saal, Johan Vallon‐Christersson, Jari Häkkinen, Cecilia Hegardt, Dorthe Grabau, Christof Winter, Christian Brueffer, Man‐Hung Eric Tang, Christel Reuterswärd, Ralph Schulz, Anna Karlsson, Anna Ehinger, Janne Malina, Jonas Manjer, Martin Malmberg, Christer Larsson, Lisa Rydén, Niklas Loman, Åke Borg - Genome Medicine 2015 cited by 285

  9. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Authors: Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H. Saal, Siker Kimbung, Ingrid Hedenfalk, Tonje G. Lien, Thérese Sørlie, Bjørn Naume, Hege G. Russnes, Rachel Marcone, Ayyakkannu Ayyanan, Cathrin Brisken, Rebecka R. Malterling, B. Asking, Helena Olofsson, Henrik Lindman, Pär‐Ola Bendahl, Anna Ehinger, Christer Larsson, Niklas Loman, Lisa Rydén, Martin Malmberg, Åke Borg, Johan Vallon‐Christersson - npj Breast Cancer 2022 cited by 99

  10. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    Authors: Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench, Douglas F. Easton, Antonis C. Antoniou, Katherine L. Nathanson, Yael Laitman, Anya Kushnir, Shani Paluch–Shimon, Raanan Berger, Jamal Zidan, Eitan Friedman, Hans Ehrencrona, Marie Stenmark‐Askmalm, Zakaria Einbeigi, Niklas Loman, Katja Harbst, Johanna Rantala, Beatrice Melin, Dezheng Huo, Olufunmilayo I. Olopade, Joyce Seldon, Patricia A. Ganz, Robert L. Nussbaum, Salina Chan, Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole and 158 more - JAMA 2015 cited by 509

  11. Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

    Authors: Christian Brueffer, Johan Vallon‐Christersson, Dorthe Grabau, Anna Ehinger, Jari Häkkinen, Cecilia Hegardt, Janne Malina, Yilun Chen, Pär‐Ola Bendahl, Jonas Manjer, Martin Malmberg, Christer Larsson, Niklas Loman, Lisa Rydén, Åke Borg, Lao H. Saal - JCO Precision Oncology 2018 cited by 221

  12. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Authors: David Miles, Eva Ciruelos, A. Schneeweiss, Fabio Puglisi, Tamar Peretz‐Yablonski, Mario Campone, Igor Bondarenko, Zbigniew Nowecki, Hassan Errihani, Shani Paluch–Shimon, A. Wardley, Jean-Louis Merot, Peter C. Trask, Yolande Du Toit, Claudia Peña-Murillo, Valentine Revelant, Dirk Klingbiel, T. Bachelot, T. Bachelot, K. Bouzid, Mario Campone, Isabelle Desmoulins, Bruno Coudert, Igor Bondarenko, Zbigniew Nowecki, I. Głogowska, Eva Ciruelos Gil, Hassan Errihani, Florence Dalenc, Francesco Ricci, Véronique Dièras, Bella Kaufman, Shani Paluch–Shimon, A. Wardley, A. Schneeweiss, Ana Filipa Ferreira, Max S. Mano, Haralabos P. Kalofonos, Claudia Andreetta, F. Puglisi, Filippo Montemurro, Sophie Barrett, Q. Zhang, Dimitriοs Mavroudis, Juan Antonio Matus, C. Villarreal Garza, C. Beato, Gustavo Ismael, Xiaoyu Hu, Hamdy Abdel Azeem, Rabab Gaafar, Christophe Perrin, Pierre Kerbrat, Johannes Ettl, Stefan Paepke, Erika Hitre, István Láng, Marc Trudeau, Sunil Verma, H. Li, Oliver Hoffmann, Bahriye Aktas, Anna Cariello, G. Cruciani, A. Tienghi, Carlo Tondini, T. Al-Twegieri, Niklas Loman, Robert Laing, David Miles, Étienne Brain, Peter A. Fasching, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, J. Fernando Salas, Joanna Streb, K. Krzemieniecki, A Wroński, J. García García, Salomón Menjón Beltrán, I. Cicin, Peter Schmid, Chris Gallagher, Nicholas C. Turner, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Zsolt Horváth, Giampaolo Bianchini, Luca Gianni, Giuseppe Curigliano, Alejandro Juárez Ramiro, Sneẑana Šušnjar, Eduarda Matos, Elena Sevillano, L. Garcia Estevez, Erhan Gökmen, Rüçhan Uslu, Hans Wildiers and 283 more - Annals of Oncology 2021 cited by 89

  13. Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

    Authors: Susan M. Domchek, Carol Aghajanian, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Niklas Loman, Jane Robertson, Helen Mann, Bella Kaufman - Gynecologic Oncology 2015 cited by 300

  14. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

    Authors: Dominik Głodzik, Ana Bosch, Johan Hartman, Mattias Aine, Johan Vallon‐Christersson, Christel Reuterswärd, Anna Karlsson, Shamik Mitra, Emma Niméus, Karolina Holm, Jari Häkkinen, Cecilia Hegardt, Lao H. Saal, Christer Larsson, Martin Malmberg, Lisa Rydén, Anna Ehinger, Niklas Loman, Anders Kvist, Hans Ehrencrona, Serena Nik‐Zainal, Åke Borg, Johan Staaf - Nature Communications 2020 cited by 136

  15. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

    Authors: Anna-Maria Larsson, Sara Jansson, Pär‐Ola Bendahl, Charlotte Levin Tykjær Jørgensen, Niklas Loman, Cecilia Graffman, Lotta Lundgren, Kristina Aaltonen, Lisa Rydén - Breast Cancer Research 2018 cited by 130

  16. Refinement of breast cancer molecular classification by miRNA expression profiles

    Authors: Rolf Søkilde, Helena Persson, Anna Ehinger, Anna Chiara Pirona, Mårten Fernö, Cecilia Hegardt, Christer Larsson, Niklas Loman, Martin Malmberg, Lisa Rydén, Lao H. Saal, Åke Borg, Johan Vallon‐Christersson, Carlos Rovira - BMC Genomics 2019 cited by 104

  17. The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

    Authors: Christian Brueffer, Sergii Gladchuk, Christof Winter, Johan Vallon‐Christersson, Cecilia Hegardt, Jari Häkkinen, Anthony M. George, Yilun Chen, Anna Ehinger, Christer Larsson, Niklas Loman, Martin Malmberg, Lisa Rydén, Åke Borg, Lao H. Saal - EMBO Molecular Medicine 2020 cited by 69

  18. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

    Authors: Olöf Bjarnadottir, Quinci Romero, Pär‐Ola Bendahl, Karin Jirström, Lisa Rydén, Niklas Loman, Mathias Uhlén, Henrik Johannesson, Carsten Rose, Dorthe Grabau, Signe Borgquist - Breast Cancer Research and Treatment 2013 cited by 236

  19. Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

    Authors: Sibylle Loibl, Chiun‐Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Charles E. Geyer, Michael Untch, Jean‐Christophe Théry, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C. Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark - npj Breast Cancer 2022 cited by 40

  20. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

    Authors: Thomas Bachelot, Eva Ciruelos, Andreas Schneeweiß, Fabio Puglisi, Tamar Peretz‐Yablonski, Igor Bondarenko, Shani Paluch–Shimon, Andrew Wardley, Jean-Louis Merot, Yolande Du Toit, V. Easton, Nicolas Lindegger, David Miles, Kamel Bouzid, Mario Campone, Bruno Coudert, Zbigniew Nowecki, Hassan Errihani, Florence Dalenc, Ana Ferreira, Max S. Mano, Francesco Ricci, Haralabos P. Kalofonos, Claudia Andreetta, Filippo Montemurro, Sophie Barrett, Qingyuan Zhang, Dimitris Mavroudis, Juan Antonio Matus, Carlos Beato, Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, István Láng, Sunil Verma, Huiping Li, Étienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, Fernando Palacios Salas, Joanna Streb, A Wroński, Salomón Menjón Beltrán, İrfan Çiçin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Sneẑana Šušnjar, Erika Matos, Rüçhan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomon M. Stemmer, Flavia Morales Vásquez, Adriana Domínguez, Marek Z. Wojtukiewicz, Jasna Trifunović, José Juan Illarramendi, Laura García, Y. Izarzugaza Perón, María José Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard de Boer, Guy Jérusalem, Véronique Cocquyt, Carlos H. Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, M. Gozy, G. Vasilopoulos, János Révész, Luciano Latini, Cesare Gridelli, Jesus Miguel Lazaro, Antonio González, A. Barnadas Molins, Eduardo Martinez, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard D. Baird and 193 more - Annals of Oncology 2019 cited by 113

  21. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Authors: Looket Dihge, Johan Vallon‐Christersson, Cecilia Hegardt, Lao H. Saal, Jari Häkkinen, Christer Larsson, Anna Ehinger, Niklas Loman, Martin Malmberg, Pär‐Ola Bendahl, Åke Borg, Johan Staaf, Lisa Rydén - Clinical Cancer Research 2019 cited by 55

  22. Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

    Authors: Kang Wang, Ioannis Zerdes, Henrik J. Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C. Kanellis, Emmanouil G. Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiří Bártek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis - Nature Communications 2024 cited by 23

  23. Gene-Expression Profiles in Hereditary Breast Cancer

    Authors: Ingrid Hedenfalk, David Duggan, Yidong Chen, Michael D. Radmacher, Michael Bittner, Richard H. Simon, Paul S. Meltzer, B.A. Gusterson, Manel Esteller, Mark Raffeld, Zohar Yakhini, Amir Ben-Dor, Edward Dougherty, Juha Kononen, Lukas Bubendorf, Wilfrid Fehrle, Stefania Pittaluga, Sofia Gruvberger, Niklas Loman, Oskar Johannsson, Håkan Olsson, Benjamin Wilfond, Guido Sauter, Olli-P. Kallioniemi, Åke Borg, Jeffrey Trent - New England Journal of Medicine 2001 cited by 1,744

  24. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic

    Authors: Christof Winter, Martin Nilsson, Eric Olsson, Anthony M. George, Y. Chen, Anders Kvist, Therese Törngren, Johan Vallon‐Christersson, Cecilia Hegardt, Jari Häkkinen, Göran Jönsson, Dorthe Grabau, Martin Malmberg, Ulf Kristoffersson, Matilda Rehn, Sofia K. Gruvberger-Saal, Catharina Larsson, Åke Borg, Niklas Loman, Lao H. Saal - Annals of Oncology 2016 cited by 150